| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2971910 | The Journal of Heart and Lung Transplantation | 2009 | 7 Pages |
Abstract
CMV+ serology at time of pediatric heart transplantation had no demonstrable association with death or development of CAV. CMVâ recipients who receive a CMV+ organ are at increased risk of clinical CMV disease. CMV prophylaxis was commonly used, although further studies are needed to establish an optimal approach for prevention of CMV disease in this population.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
William T. MD, Margaret T. Fourshee, David M. PhD, Juan C. MD, Randall L. MD, Karen PhD, Alexandria MSN, Kirk R. MD, Pediatric Heart Transplant Study Group Pediatric Heart Transplant Study Group,